Joint event of the BeNeLux Chamber of Commerce and the “QazBioPharm” Holding

On February 20, 2024, a seminar “Attracting investment and localizing production of JSC National Holding QazBioPharm” was held in Astana for trade and economic advisors of EU embassies and representatives of European pharmaceutical companies. The seminar was the first event organized within the framework of the memorandum of understanding and cooperation between the BeNeLux Chamber of Commerce and the QazBioPharm Holding, which was signed in January 2024 years. The event was organized with the assistance of the EU Delegation to the Republic of Kazakhstan.

The meeting was attended by the heads of JSC National Holding QazBioPharm, the BeNeLux Chamber of Commerce, representatives of the diplomatic missions of Belgium, the Netherlands, Bulgaria, Latvia, Croatia, the EU, as well as representatives of Nazarbayev University, the pharmaceutical company AstraZeneca.

JSC National Holding QazBioPharm presented 8 organizations that are part of it (Research Institute for Biological Safety Problems, OtarBioPharm Plant, National Center for Biotechnology, National Scientific Center for Particularly Dangerous Infections named after M. Aikimbaev, Kazakh Research Veterinary Institute, Scientific Center for Anti-Infective Drugs, Republican Collection of Microorganisms, Scientific and Analytical Center "BioMedPreparat") and introduced them to the specifics of their activities. The main issue of the meeting was attracting European investments and localizing innovative pharmaceutical products on the territory of the Republic of Kazakhstan.
Representatives of European diplomatic missions expressed interest in cooperation in the field of pharmaceutical production, joint development of drugs, and personnel training.

At the end of the meeting, a familiarization visit to several laboratories of the QazBioPharm Holding was organized for the participants.

For reference:
QazBioPharm is a national holding company that is engaged in research and development in the field of biotechnology. Establishment date: July 2022

HOLDING MISSION:
Effective management of legal entities, state shares in the authorized capital of which are transferred to the ownership and use of the Holding in order to ensure biological safety, sustainable development and improvement of the infrastructure of the biopharmaceutical market, stimulate the development of biopharmaceutical science and industry, as well as meet the needs of the state and society for biopharmaceutical products.